Watertown, United States
Seismic Therapeutic™, known as The Machine Learning Immunology Company, is pioneering a revolutionary approach in immunology therapy development using advanced machine learning technologies. Founded in 2020, this United States-based biotechnology startup is making strides in healthcare by harnessing its unique IMPACT platform to develop best-in-class and first-in-class biologics aimed at modulating dysregulated adaptive immunity. Seismic Therapeutic is strategically located in Boston, a hub for innovative biotechnological advancement.
The company has successfully secured significant financial backing, most recently raising $121.00M in a Series B investment on 04 December 2023. This funding round attracted participation from notable investors including Bessemer Venture Partners, Gaingels, Lightspeed Venture Partners, Amgen Ventures, GV, Alexandria Venture Investments, Codon Capital, Samsara BioCapital, Timothy A. Springer, and GC&H Investments. Seismic's emerging preclinical pipeline positions it as a leading entity poised to transform autoimmune disease treatments.
